Physician profile
Hasan Askari
NPI 1700940277
$1,269.02
in general payments reported to CMS, 2019-2025
15 companies · $16.00 in 2025
The $16.00 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,124 · 2020: $102 · 2021: $26.62 · 2025: $16.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $645.73 | 2019 | |
| Ucb, INC. | $105.20 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $102.32 | 2020 | |
| Sunovion Pharmaceuticals INC. | $78.03 | 2019 | |
| Lilly USA, LLC | $60.36 | 2019 | |
| Genzyme Corporation | $45.94 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $39.86 | 2019 | |
| Supernus Pharmaceuticals, INC. | $37.74 | 2019 | |
| Biogen, INC. | $33.29 | 2019 | |
| Avanir Pharmaceuticals, INC. | $25.25 | 2019 | |
| Alexion Pharmaceuticals, INC. | $24.78 | 2019 | |
| Upsher-Smith Laboratories LLC | $21.08 | 2019 | |
| Emd Serono, INC. | $18.75 | 2019 | |
| Amgen INC. | $16.00 | 2025 | Uplizna |
| Mdd US Operations, LLC | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasan Askari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.